SCOTTSDALE, Ariz., March 30, 2006 (PRIMEZONE) -- Motion DNA Corporation (Pink Sheets:MTDX) and the National Profastpitch League (NPF) announced today plans to renew the agreement between the nation's leading biomechanical anlaysis company and the women's professional sports league.
Final terms of the deal were not yet finalized, but deal points are expected to include an cash, marketing exposure for both organizations and more involvement by Motion DNA in the health and well being of athletes on the leagues six teams.
In 2005, Motion DNA signed an agreement to become the leagues provider of biomechanical testing of athletes in an effort to reduce injuries and improve performances. Every athlete in the league received at least one analysis and reports recommending physical and biomechanical adjustments, including the leagues stars like Olympians Jennie Finch, Lovie Jung, Lauren Bay, Crystal Bustos, and more.
The NPF also agreed to assist Motion DNA in locating additional strategic licensees of its technology the local markets where the league has a presence. The NPF is also expected to assist in the facilitation of relationship between Motion DNA and the national governing body for softball in the United States, Amateur Softball Association (ASA). Motion DNA will begin testing athletes again in May at the league's preseason training sites.
About Motion DNA Corporation
Based in Scottsdale, Ariz., Motion DNA has developed state-of-art products and services that incorporate advanced 3-D motion-capture technology, which provides diagnostic testing for individual athletes, medical professionals and sports organizations. These types of analyses are designed to identify physical limitations related to strength, mobility, coordination and biomechanics.
Forward-Looking Statements
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications that may arise could prevent the prompt implementation of any strategically significant plan(s) outlined above. The company cautions that these forward-looking statements are further qualified by other factors. The company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise.
The Motion DNA Corporation logo is available at: http://www.primezone.com/newsroom/prs/?pkgid=2484